Boehringer Ingelheim to Invest €50 Million to Build Pilot Plant for New APIs

Boehringer Ingelheim (Ingelheim, Germany) says it will build a new pilot plant facility for the production of newly developed active pharmaceutical ingredients (APIs) at the company’s research and development site at Biberach, Germany. The project will involve an investment of over €50 million ($62 million). Construction of the new facility is scheduled for completion in early 2014. With the new facility, Boehringer Ingelheim aims to ensure that the substances from the well-stocked research pipeline, or the supply of innovative compounds, are available...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers